This person does not currently hold a position at QUT.
Bob Biggar is Professor of Research Development at IHBI. He works closely with Profs. Ross Young and Michael Kimlin. By training, he is a physician (paediatrics with infectious diseases subspeciality) and epidemiologist. After a 30 year career at the Natonal Institutes of Health (USA), he worked in Denmark, France and India. His main research has been in 4 fields: HIV/AIDS, immunity, cancer, and health problems affecting infants and children. But his interests are diverse. Mainly, he has focused on population studies (e.g., risk factors and cohort studies) and natural history evaluatons but he also has experience with clinical trials and is comfortable with the evaluation of laboratory data.
He has co-authored over 300 publications and mentored many doctoral and post-doctoral students during his career. His publications can be identified in Pubmed (search for Biggar RJ). His current personal research is examining the role of commonly-used estrogen-mimicking drugs (e.g., digoxin) and their impact on breast and gynecologic cancer risks in studies being done with colleagues in Denmark. He also has an adjunct position as Senior Reseach Scientist at the Statens Serum Institutet, Copenhagen, Denmark.
He is available to anyone, from student to faculty, for discussion of science and science writing (papers or applications). He has extensive experience working in many parts of the world on diverse topics, ranging from Burkitt Lymphoma research (involving EBV and malaria studies) in Ghana, West Africa to studies of retroviruses in Amerindians living in the Amazon Basin, to TB in Greenland. He would welcome an opportuntiy to hear about your studies.
Other Medical and Health Sciences
Field of Research code, Australian and New Zealand Standard Research Classification (ANZSRC), 2008
- Doctor of Medicine, Baylor College of Medicine